Drug intelligence / Profile preview

EBP11-F4

Development stage
Unknown
Lead developer
Entera Bio
Modality
Peptides
Administration
Oral
01

Overview

EBP11-F4 is an investigational oral formulation of human parathyroid hormone (1-34), also known as teriparatide, developed by Entera Bio using its proprietary oral delivery technology. This technology is designed to enable the oral administration of large molecules and peptides by utilizing a synthetic absorption enhancer to facilitate transport across the intestinal wall and a protease inhibitor to prevent degradation by digestive enzymes. EBP11-F4 is being evaluated in clinical trials for conditions requiring PTH replacement or bone-building therapy, including hypoparathyroidism, osteoporosis, and bone fractures. As an agonist of the parathyroid hormone receptor 1 (PTH1R), it regulates calcium and phosphate homeostasis and promotes bone formation by stimulating osteoblast activity.

Other names
oral hPTH(1-34) formulation F4
02

Targets

PTH1R (Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1)

Beyond the preview

Go deeper on EBP11-F4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EBP11-F4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call